Jennifer Gori, PhD, on the Potential of a Prime Editing Approach in Treating Chronic Granulomatous Disease
The vice president of research at Prime Medicine discussed a preclinical study on a novel autologous HSCT treatment that was presented at ASGCT’s 2023 annual meeting.